Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$139.97M
Total Bought:
$82.03M
Total Sold:
$128.92M
Net Transaction:
-$46.88M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Summit Therapeutics Inc.(SMMT)0892,873+892,873$0$16.93M12.09%+$16.93M
Immunovant, Inc.(IMVT)288,677357,606+68,929$7.34M$8.88M6.35%+$1.54M
Cogent Biosciences, Inc.(COGT)366,238225,158-141,080$13.01M$8.67M6.19%-$4.34M
Savara Inc.(SVRA)995,3531,585,977+590,624$6.00M$8.66M6.19%+$2.66M
UroGen Pharma Ltd.(URGN)718,354387,371-330,983$16.82M$6.96M4.98%-$9.86M
Definium Therapeutics, Inc.(DFTX)0351,461+351,461$0$6.64M4.75%+$6.64M
Vir Biotechnology, Inc.(VIR)0730,548+730,548$0$6.55M4.68%+$6.55M
Vaxcyte, Inc.(PCVX)0110,454+110,454$0$6.42M4.59%+$6.42M
Celldex Therapeutics, Inc.(CLDX)88,308180,048+91,740$2.40M$5.71M4.08%+$3.31M
Sionna Therapeutics, Inc.(SION)180,593141,024-39,569$7.43M$5.65M4.04%-$1.78M
Genmab A/SADS(GMAB)29,162196,709+167,547$898.2K$5.28M3.77%+$4.38M
Zai Lab LimitedADR(ZLAB)196,853275,818+78,965$3.47M$5.19M3.71%+$1.72M
Vertex Pharmaceuticals Incorporated(VRTX)011,010+11,010$0$4.92M3.51%+$4.92M
IQVIA Holdings Inc.(IQV)025,668+25,668$0$4.38M3.13%+$4.38M
MapLight Therapeutics, Inc.(MPLT)0192,139+192,139$0$3.91M2.79%+$3.91M
Arvinas, Inc.(ARVN)0312,620+312,620$0$3.31M2.37%+$3.31M
Oruka Therapeutics, Inc.(ORKA)063,591+63,591$0$3.12M2.23%+$3.12M
United Therapeutics Corporation(UTHR)9,4515,186-4,265$4.61M$3.08M2.20%-$1.53M
Travere Therapeutics, Inc.(TVTX)38,022102,754+64,732$1.45M$3.05M2.18%+$1.60M
Trevi Therapeutics, Inc.(TRVI)148,292251,566+103,274$1.86M$3.00M2.14%+$1.14M
Adlai Nortye Group Ltd.ADS(ANL)0414,852+414,852$0$2.87M2.05%+$2.87M
Cabaletta Bio, Inc.(CABA)2,253,5501,066,239-1,187,311$4.94M$2.87M2.05%-$2.07M
Pfizer Inc.(PFE)074,000+74,000$0$2.08M1.48%+$2.08M
Axsome Therapeutics, Inc.(AXSM)37,43311,217-26,216$6.84M$1.90M1.35%-$4.94M
ORIC Pharmaceuticals, Inc.(ORIC)255,370115,234-140,136$2.09M$1.46M1.04%-$628.9K
Aclaris Therapeutics, Inc.(ACRS)0366,490+366,490$0$1.37M0.98%+$1.37M
Climb Bio, Inc.(CLYM)0199,209+199,209$0$1.36M0.97%+$1.36M
Taysha Gene Therapies, Inc.(TSHA)980,768258,269-722,499$5.39M$1.15M0.82%-$4.24M
Bright Minds Biosciences Inc.(DRUG)47,27813,311-33,967$3.69M$971.3K0.69%-$2.72M
Tonix Pharmaceuticals Holding Corp.(TNXP)063,540+63,540$0$873.7K0.62%+$873.7K
Cullinan Therapeutics, Inc.(CGEM)059,484+59,484$0$845.3K0.60%+$845.3K
Protara Therapeutics, Inc.(TARA)360,000121,457-238,543$1.92M$632.8K0.45%-$1.29M
Palatin Technologies, Inc.(PTN)33,97135,969+1,998$522.5K$626.6K0.45%+$104.1K
Biomea Fusion, Inc.(BMEA)250,000250,0000$310.0K$382.5K0.27%+$72.5K
Century Therapeutics, Inc.(IPSC)462,963119,308-343,655$460.6K$269.6K0.19%-$190.9K
Aardvark Therapeutics Inc69,4960-69,496$912.1K$0—-$912.1K
Amicus Therapeutics Inc
COM
352,8960-352,896$5.03M$0—-$5.03M
Assembly Biosciences Inc65,2730-65,273$2.22M$0—-$2.22M
Avalo Therapeutics, Inc.(AVTX)153,3130-153,313$2.78M$0—-$2.78M
Belite Bio, IncADS(BLTE)24,7030-24,703$3.95M$0—-$3.95M
Capricor Therapeutics, Inc.(CAPR)96,3340-96,334$2.78M$0—-$2.78M
Cidara Therapeutics Inc85,0980-85,098$18.80M$0—-$18.80M
Dianthus Therapeutics, Inc.(DNTH)26,2490-26,249$1.08M$0—-$1.08M
Dynavax Technologies Corp525,5920-525,592$8.08M$0—-$8.08M
Entera Bio Ltd.SHS(ENTX)17,1420-17,142$33.3K$0—-$33.3K
Fulcrum Therapeutics, Inc.(FULC)72,0600-72,060$815.0K$0—-$815.0K
Inventiva S.A.ADS(IVA)100,0000-100,000$465.0K$0—-$465.0K
Mind Medicine Mindmed Inc425,2020-425,202$5.69M$0—-$5.69M
Ocular Therapeutix, Inc.(OCUL)418,0800-418,080$5.08M$0—-$5.08M
Palisade Bio, Inc.(PALI)367,1030-367,103$862.7K$0—-$862.7K
Palvella Therapeutics, Inc.(PVLA)25,4690-25,469$2.67M$0—-$2.67M
IRulya Therapeutics Inc.(IRLA)858,7110-858,711$2.88M$0—-$2.88M
Revolution Medicines, Inc.(RVMD)54,8790-54,879$4.37M$0—-$4.37M
Rezolute, Inc.(RZLT)513,7650-513,765$1.21M$0—-$1.21M
Spruce Biosciences Inc12,1370-12,137$1.06M$0—-$1.06M
Terns Pharmaceuticals Inc443,7770-443,777$17.93M$0—-$17.93M
Tyra Biosciences, Inc.(TYRA)58,6770-58,677$1.54M$0—-$1.54M
Ultragenyx Pharmaceutical Inc.(RARE)31,7380-31,738$730.0K$0—-$730.0K
Viridian Therapeutics, Inc.(VRDN)43,2300-43,230$1.35M$0—-$1.35M
Zenas BioPharma, Inc.(ZBIO)83,3530-83,353$3.03M$0—-$3.03M
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q1 2026 | TickerTrail